INMB Key Financial Ratios - Inmune Bio, Inc.

Complete source-backed ratio history.

Historical Key Financial Ratios

Date	Current ratio	Debt/equity	ROA	ROE
2026-06-30	4.04	—	-68.60%	-90.44%
2026-03-31	4.24	—	-161.13%	-211.99%
2025-12-31	3.55	—	-141.98%	-195.26%
2025-09-30	4.17	—	-149.55%	-196.58%
2025-06-30	4.2	—	-147.30%	-192.29%
2025-03-31	2.64	—	-107.92%	-137.49%
2024-12-31	3.14	—	-106.37%	-131.11%
2024-09-30	2.59	—	-78.19%	-106.71%
2024-06-30	2.36	—	-71.95%	-104.03%
2024-03-31	1.71	—	-73.66%	-122.23%
2023-12-31	2.16	—	-52.64%	-80.36%
2023-09-30	3.18	—	-43.75%	-62.44%
2023-06-30	4.03	—	-38.15%	-52.50%
2023-03-31	5.53	—	-36.40%	-48.71%
2022-12-31	5.92	0.24	-33.37%	-45.42%
2022-09-30	9.67	—	-37.16%	-48.88%
2022-06-30	30.87	—	-37.43%	-47.00%
2022-03-31	23.89	—	-34.64%	-43.21%
2021-12-31	18.95	—	-30.36%	-37.82%
2021-09-30	18.9	—	-22.17%	-27.05%
2021-06-30	14.74	—	-31.52%	-44.25%
2021-03-31	22.41	—	-22.14%	-22.95%
2020-12-31	13.51	—	-29.76%	-31.22%
2020-09-30	17.73	—	-26.19%	-27.21%
2020-06-30	5.22	—	-41.49%	-44.10%
2020-03-31	6.25	—	-33.14%	-35.02%
2019-12-31	11.09	—	-31.38%	-32.52%
2019-09-30	16.84	—	-28.51%	-29.30%
2019-06-30	20.96	—	-20.75%	-21.29%
2019-03-31	—	—	-48.61%	-50.27%
2018-12-31	1.03	—	-71.65%	-75.21%

Date	Current ratio	Debt/equity	ROA	ROE
2025-12-31	3.55	—	-141.98%	-195.26%
2024-12-31	3.14	—	-106.37%	-131.11%
2023-12-31	2.16	—	-52.64%	-80.36%
2022-12-31	5.92	0.24	-33.37%	-45.42%
2021-12-31	18.95	—	-30.36%	-37.82%
2020-12-31	13.51	—	-29.76%	-31.22%
2019-12-31	11.09	—	-31.38%	-32.52%
2018-12-31	1.03	—	-71.65%	-75.21%
2017-12-31	—	—	-4.52%	-4.59%